Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...
Ann Marie Rogers won a landmark victory to make the breast cancer drug Herceptin more widely available. Here, she explains what drove her. But others are asking if the treatment really lives up to ...
The FDA has approved a new biosimilar of Roche’s breast cancer drug Herceptin, from Samsung Bioepis and Merck & Co, ahead of the original drug’s US patent expiry in June. Developed by Samsung ...
Antibody-drug conjugates (ADCs) are new drugs that combine a monoclonal antibody with a chemotherapy drug. They can specifically target cancer cells to deliver potent chemotherapy drugs.
An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...
Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...
Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...
The global breast cancer drugs market size was valued at USD 34.25 billion in 2024 and is projected to reach from USD 37.30 ...
AstraZeneca and Daiichi Sankyo's Enhertu has become the first HER2-directed drug to mount a patient survival benefit in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback